EXPANDING PREVENTING THERAPY FOR TUBERCULOUS INFECTION

扩大结核感染的预防治疗

• 批准号: 6532599
• 负责人: ROBERT M JASMER
• 金额: $ 11.64万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-30 至 2003-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6532599
• 关键词: Mycobacterium tuberculosis; antitubercular agents; chemoprevention; clinical research; clinical trials; communicable disease control; disease /disorder proneness /risk; drug adverse effect; drug screening /evaluation; human subject; human therapy evaluation; isoniazid; latent bacterial disease; longitudinal human study; respiratory disorder chemotherapy; restriction fragment length polymorphism; rifamycins; self care; tuberculosis

项目成果

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.

短程利福平和吡嗪酰胺与异烟肼治疗潜伏性结核感染的比较：基于多中心临床试验的成本效益分析。

• DOI: 10.1086/380966
• 发表时间: 2004
• 期刊: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
• 作者: Jasmer,RobertM;Snyder,DavidC;Saukkonen,JussiJ;Hopewell,PhilipC;Bernardo,John;King,MarkD;Kawamura,LMasae;Daley,CharlesL;Short-CourseRifampinandPyrazinamideforTuberculosisInfectionStudyInvestigators
• 通讯作者: Short-CourseRifampinandPyrazinamideforTuberculosisInfectionStudyInvestigators

Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.

Fc 片段在抗体介导的眼部和皮下单纯疱疹病毒感染恢复中的作用。

• DOI: 10.1128/iai.33.1.109-114.1981
• 发表时间: 1981
• 期刊: Infection and immunity
• 影响因子: 3.1
• 作者: Oakes,JE;Lausch,RN
• 通讯作者: Lausch,RN